Bristol Myers Squibb Expands Health Equity Grant Initiatives to Improve Health Outcomes - Seite 2

At Bristol Myers Squibb, health equity is the opportunity for all people and communities across the globe to attain their full potential for health and well-being. Our work extends beyond traditional healthcare boundaries, emphasizing the importance of community voices and cross-sector partnerships in co-creating solutions that drive meaningful and equitable health outcomes worldwide.

About Bristol Myers Squibb

Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop, and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol Myers Squibb, please visit BMS.com or follow us on LinkedIn, Twitter, YouTube, Facebook, and Instagram.

philanthropy-news

______________________________

¹ Hood CM, Gennuso KP, Swain GR, et al. County Health Rankings: Relationships Between Determinant Factors and Health Outcomes. American Journal of Preventive Medicine. February 2016; 50(2):129-135. doi:10.1016/j.amepre.2015.08.024
² United Nations Department of Economic and Social Affairs – Sustainable Development. The 17 Goals. Available at https://sdgs.un.org/goals. Accessed March 2024.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240322756721/en/

The Bristol-Myers Squibb Stock at the time of publication of the news with a raise of +0,21 % to 48,30EUR on Tradegate stock exchange (26. März 2024, 09:47 Uhr).